Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Frontiers in Immunology|May 28, 2019
Human Gut-Associated Natural Killer Cells in Health and DiseaseAlessandro Poggi, Roberto Benelli, Roberta Venè, et al.Plos One|February 23, 2012
Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patientsBarbara M Colombo, Paolo Canevali, Ottavia Magnani, et al.Blood|September 16, 2006
Expansion of Vdelta1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16-binding proteinsSilvia Catellani, Alessandro Poggi, Andrea Bruzzone, et al.Blood|April 28, 2009
Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicansDaniela Fenoglio, Alessandro Poggi, Silvia Catellani, et al.Journal for Immunotherapy of Cancer|December 21, 2022
Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximabRoberto Benelli, Delfina Costa, Laura Salvini, et al.Cancers|February 11, 2023
Priming of Colorectal Tumor-Associated Fibroblasts with Zoledronic Acid Conjugated to the Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Elicits Anti-Tumor Vδ2 T LymphocytesJordi Leonardo Castrillo Fernandez, Roberto Benelli, Delfina Costa, et al.Blood|October 24, 2002
Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interactionGrazia Maria Spaggiari, Paola Contini, Alessandra Dondero, et al.Blood|October 24, 2002
Transendothelial migration leads to protection from starvation-induced apoptosis in CD34+CD14+ circulating precursors: evidence for PECAM-1 involvement through Akt/PKB activationElisabetta Ferrero, Daniela Belloni, Paola Contini, et al.Cancers|January 8, 2020
Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal CancerDaniele Di Mascolo, Serena Varesano, Roberto Benelli, et al.European Journal of Medicinal Chemistry|February 13, 2016
Discovery of a new selective inhibitor of A Disintegrin And Metalloprotease 10 (ADAM-10) able to reduce the shedding of NKG2D ligands in Hodgkin's lymphoma cell modelsCaterina Camodeca, Elisa Nuti, Livia Tepshi, et al.Pageof 7